Division of General Internal Medicine, University Texas Southwestern Medical Center, Dallas, Texas.
Divsion of Hospital Medicine, University of California San Francisco, San Francisco, California.
J Hosp Med. 2015 Jun;10(6):396-402. doi: 10.1002/jhm.2347. Epub 2015 Mar 11.
Although timely treatment of sepsis improves outcomes, delays in administering evidence-based therapies are common.
To determine whether automated real-time electronic sepsis alerts can: (1) accurately identify sepsis and (2) improve process measures and outcomes.
We systematically searched MEDLINE, Embase, The Cochrane Library, and Cumulative Index to Nursing and Allied Health Literature from database inception through June 27, 2014.
Included studies that empirically evaluated 1 or both of the prespecified objectives.
Two independent reviewers extracted data and assessed the risk of bias. Diagnostic accuracy of sepsis identification was measured by sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and likelihood ratio (LR). Effectiveness was assessed by changes in sepsis care process measures and outcomes.
Of 1293 citations, 8 studies met inclusion criteria, 5 for the identification of sepsis (n = 35,423) and 5 for the effectiveness of sepsis alerts (n = 6894). Though definition of sepsis alert thresholds varied, most included systemic inflammatory response syndrome criteria ± evidence of shock. Diagnostic accuracy varied greatly, with PPV ranging from 20.5% to 53.8%, NPV 76.5% to 99.7%, LR+ 1.2 to 145.8, and LR- 0.06 to 0.86. There was modest evidence for improvement in process measures (ie, antibiotic escalation), but only among patients in non-critical care settings; there were no corresponding improvements in mortality or length of stay. Minimal data were reported on potential harms due to false positive alerts.
Automated sepsis alerts derived from electronic health data may improve care processes but tend to have poor PPV and do not improve mortality or length of stay.
尽管及时治疗脓毒症可改善预后,但在实施基于证据的治疗方面往往存在延迟。
旨在确定自动化实时电子脓毒症警报是否可以:(1)准确识别脓毒症,(2)改善流程指标和结局。
我们系统地检索了 MEDLINE、Embase、The Cochrane Library 和 Cumulative Index to Nursing and Allied Health Literature,检索时间从数据库建立至 2014 年 6 月 27 日。
纳入的研究均是对预先设定的目标之一或两者进行实证评估的研究。
两名独立的审查员提取资料并评估偏倚风险。脓毒症识别的诊断准确性通过灵敏度、特异度、阳性预测值(PPV)、阴性预测值(NPV)和似然比(LR)进行衡量。通过脓毒症治疗过程指标和结局的变化来评估有效性。
在 1293 篇引用文献中,有 8 项研究符合纳入标准,其中 5 项研究用于识别脓毒症(n=35423),5 项研究用于评估脓毒症警报的效果(n=6894)。尽管脓毒症警报阈值的定义存在差异,但大多数研究都纳入了全身炎症反应综合征标准和/或休克的证据。诊断准确性差异较大,PPV 范围为 20.5%至 53.8%,NPV 为 76.5%至 99.7%,LR+为 1.2 至 145.8,LR-为 0.06 至 0.86。在非重症监护环境下,患者的治疗流程指标(如抗生素升级)有适度改善,但死亡率或住院时间没有相应改善。由于假阳性警报导致的潜在危害仅有少量数据报道。
从电子健康数据中提取的自动化脓毒症警报可能会改善治疗流程,但往往 PPV 较差,且不会改善死亡率或住院时间。